Compounded semaglutide

Bioverse

Bioverse advertises $129 a month for compounded semaglutide. We have not been able to confirm what the card is actually charged. That is the starting dose, and it rises as your dose does.

Advertised monthly$129
EvidenceReported
Billing cyclenot confirmed
Price across dosesClimbs with the dose
Where it ships10 states
FDA warning letterOne on filestill listed here

Visit Bioverse →

What it bills, and what that is per month

The $129 above is the seller's own monthly figure. It does not say how often the card is actually charged, so we cannot restate it over a calendar month or check it against a checkout. When that changes, the arithmetic appears here.

The price above is the starting dose, and it rises as your dose does. This seller does not publish how far, so treat it as an entry price rather than what you will be paying in six months.

Where it says it operates

Listed in 10 states.

Named on its own site.

What else this seller sells

The same seller appears in our data for one other medication.

Each figure is a real month for that medication, and none of it is part of the compounded semaglutide price above. How the two molecules compare at every seller that sells both: compounded semaglutide vs compounded tirzepatide.

FDA has written to this seller

In , FDA sent warning letter 716508 to Bioverse, Inc. dba Bioverse (New York, NY). The letter’s subject:

Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)

Read the letter on fda.gov · The letter names gobioverse.com — the same site this page links to.

This seller stays in the index, at its real price. A warning letter is something you should see and weigh for yourself — an index that quietly dropped the worst records would be least useful exactly when it matters most. How we screen for these →